RECRUITING

NYC Cancer Outreach Network in Neighborhoods for Equity and Community Translation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

NYC CONNECT will carry out a randomized controlled trial (RCT) which will assess the relative effectiveness of two evidence-based strategies to increase cancer screening rates for breast, cervical, and colorectal cancer. The RCT will compare the effectiveness of using a combination of 1) culturally and linguistically tailored cancer education materials and 2) community health workers (CHWs) to provide navigation services for cancer screening (the "patient navigation" \[PN\] arm) versus providing culturally and linguistically tailored cancer education only (the "less intensive" \[LI\] arm). The study population will include individuals who are due for breast, cervical, or colorectal cancer screening. All individuals recruited to the study will be provided navigation for unmet social determinants of health (SDH) needs.

Official Title

NYC Cancer Outreach Network in Neighborhoods for Equity and Community Translation Randomized Controlled Trial (NYC CONNECT)

Quick Facts

Study Start:2023-07-05
Study Completion:2026-10-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05742178

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:21 Years to 75 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Women between the ages of 21 and 75 years;
  2. * Men between the ages of 50 and 75 years;
  3. * Women (50-74 years) who have not had a mammogram in the past 24 months, a Pap smear in the last 3 years (21-64 years old) or HPV test in the last 5 years (30-64 years old), or women 50-75 years old who are not up-to-date on colorectal cancer screening (Fecal occult blood test (FOBT)/Fecal immunochemical test (FIT) past year, computerized tomography (CT) colonography or sigmoidoscopy past 5 years, or colonoscopy past 10 years);
  4. * Men not up-to-date on colorectal cancer screening (FOBT/FIT past year, computerized tomography (CT) colonography or sigmoidoscopy past 5 years, or colonoscopy past 10 years);
  5. * Must speak either English, Spanish, Haitian-Creole, or Chinese Mandarin;
  6. * Lives in East Flatbush (zip codes: 11236, 11203, 11212); Sunset Park (zip codes: 11215, 11220, 11232); Highbridge (zip code 10452); or Morrisania (zip codes: 10456, 10459)
  1. * Previous or current diagnosis of any cancer;
  2. * Pregnancy (breast and cervical cancer only);
  3. * Current participation in an existing cancer navigation program;
  4. * Currently in hospice care;
  5. * At least 66 years of age with advanced illness or frailty or who live in long-term institution for more than 90 days;
  6. * Bilateral mastectomy or right and left unilateral mastectomy (breast cancer only);
  7. * Hysterectomy with no residual cervix (cervical cancer only);
  8. * Total colectomy (colorectal cancer only).

Contacts and Locations

Study Contact

Chau Trinh-Shevrin, DrPH
CONTACT
646-501-3480
chau.trinh@nyulangone.org
Perla Chebli, PhD
CONTACT
646-501-3524
perla.chebli@nyulangone.org

Principal Investigator

Chau Trinh, PhD
PRINCIPAL_INVESTIGATOR
NYU Langone Health

Study Locations (Sites)

Albert Einstein College of Medicine
Bronx, New York, 10461
United States
NYU Langone Health
New York, New York, 10016
United States

Collaborators and Investigators

Sponsor: NYU Langone Health

  • Chau Trinh, PhD, PRINCIPAL_INVESTIGATOR, NYU Langone Health

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-07-05
Study Completion Date2026-10-01

Study Record Updates

Study Start Date2023-07-05
Study Completion Date2026-10-01

Terms related to this study

Additional Relevant MeSH Terms

  • Cancer Screening